Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Corneal Angiogenesis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Corneal Angiogenesis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazan, HE; Eastlack, JP; He, J1
Bazan, HE; Bazan, NG; Ma, X; Ottino, P1
Bazan, HE1
Bazan, NG; Cohen, RA; Gebhardt, BM1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Corneal Angiogenesis

ArticleYear
Cellular and molecular events in corneal wound healing: significance of lipid signalling.
    Experimental eye research, 2005, Volume: 80, Issue:4

    Topics: Arachidonic Acids; Cell Division; Cornea; Corneal Injuries; Corneal Neovascularization; Docosahexaenoic Acids; Eicosanoids; Epithelial Cells; Extracellular Matrix; Fibroblasts; Humans; Keratitis; Lipid Metabolism; Neuroprotective Agents; Platelet Activating Factor; Signal Transduction; Wound Healing

2005

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Corneal Angiogenesis

ArticleYear
The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF).
    Current eye research, 2010, Volume: 35, Issue:12

    Topics: Animals; Cells, Cultured; Coculture Techniques; Cornea; Corneal Neovascularization; Dihydropyridines; Endothelial Cells; Gene Expression Regulation; Humans; Myofibroblasts; Platelet Activating Factor; Rabbits; Thrombospondin 1; Umbilical Veins; Vascular Endothelial Growth Factor A

2010
Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Investigative ophthalmology & visual science, 2004, Volume: 45, Issue:9

    Topics: Animals; Antibodies; Azepines; Cattle; Cell Division; Cell Movement; Cells, Cultured; Corneal Neovascularization; Dose-Response Relationship, Drug; Endothelial Cells; Fibroblast Growth Factor 2; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Skin; Thienopyridines; Triazoles; Umbilical Veins; Up-Regulation; Vascular Endothelial Growth Factor A

2004
A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization.
    Current eye research, 1994, Volume: 13, Issue:2

    Topics: Animals; Cornea; Corneal Edema; Corneal Neovascularization; Corneal Transplantation; Diterpenes; Eosinophilia; Female; Ginkgolides; Graft Rejection; Keratitis; Lactones; Male; Platelet Activating Factor; Rabbits; Transplantation, Autologous; Transplantation, Homologous

1994